| Similar Articles |
|---|
 |
The Motley Fool
January 20, 2011
Brian Orelli |
Merck's Bleeding Out Vorapaxar caused it.   |
The Motley Fool
November 15, 2010
Brian Orelli |
A Mega-Blockbuster Showdown Boehringer Ingelheim's Pradaxa was recently approved to treat patients with an erratic heartbeat, and Bayer and Johnson & Johnson have a second compound, Xarelto, that isn't far behind. |
The Motley Fool
November 30, 2011
Brian Orelli |
Drugmakers Bleeding Out That's not what blood thinners are supposed to do. |
American Family Physician
June 15, 2005
Mark H. Ebell |
Decision-Making Tool for Treating Patients with Nonvalvular Atrial Fibrillation What is the risk of stroke in a patient with nonvalvular atrial fibrillation, and should that patient be given warfarin (Coumadin) or aspirin? |
The Motley Fool
April 6, 2011
Brian Orelli |
$1 Billion in Drug Sales Bleeds Out Don't feel too bad for Bayer and J&J though. |
AskMen.com
August 3, 2003
Mike Davison |
Are You At Risk Of Having A Stroke? Learn about this life-threatening condition that can lead to disability, brain damage, or even death. |
Pharmaceutical Executive
December 1, 2010
Walter Armstrong |
Acute Coronary Syndrome A new class of anticoagulants is competing to dethrone difficult-to-manage warfarin, long the sole option in the prevention of stroke and other bleeding complications in the 2.5 million US patients with atrial fibrillation. |
The Motley Fool
September 8, 2011
Arlene Weintraub |
Bristol-Pfizer Team on Alert as FDA Reviews Stroke-Prevention Drug From Rivals J&J and Bayer Who will come out ahead? |
American Family Physician
July 15, 2002
Dana E. King |
Acute Management of Atrial Fibrillation: Part II. Prevention of Thromboembolic Complications Family physicians should be familiar with the acute management of atrial fibrillation and the initiation of chronic therapy for this common arrhythmia. Part II of this two-part article focuses on the prevention of thromboembolic complications using anticoagulation. |
The Motley Fool
June 23, 2011
Brian Orelli |
In Addition, Our Drug Actually Rocks Pfizer and Bristol get good data on Eliquis. |
The Motley Fool
August 24, 2011
Alexander Crawford |
Pfizer & Bristol-Myers to Release Highly Anticipated Data on Bloodthinner Hopeful How big could this market be? |
BusinessWeek
November 19, 2007
Catherine Arnst |
A Top Gun Takes Aim at Strokes Jackson Streeter left his dream job as a fighter pilot to tackle stokes, the second leading cause of death. |
The Motley Fool
July 10, 2007
Brian Orelli |
Sometimes, the Same Is Good Enough Bristol-Myers Squibb's new drug doesn't work better, but it's easier to take. Investors, take note. |
Nursing
February 2012
Pezzotti & Freuler |
Using anticoagulants to steer clear of clots This article will review coagulation and provide important information about several commonly used anticoagulants and their reversal agents. |
American Family Physician
December 15, 2003
Ezekowitz et al. |
Stroke: Strategies for Primary Prevention Stroke is a leading cause of morbidity and mortality. Every year, approximately 500,000 Americans have a first stroke, and approximately 20 percent die within 30 days. This article summarizes strategies that have been shown to be effective in stroke prevention. |
The Motley Fool
October 26, 2010
Brian Orelli |
Where's the Growth in Big Pharma? The theme for the pharmaceutical industry's 2010 third-quarter earnings reports has been officially set: If you can't get it done through sales, just cut costs. |
Wired
March 2006
Jennifer Kahn |
A Nation of Guinea Pigs There's a new outsourcing boom in South Asia - and a billion people are jockeying for the jobs. How India became the global hot spot for drug trials. |
AskMen.com
Joshua Levine |
Preventing A Heart Attack: Part I The warnings signs of a stroke, types of strokes, prevention, and rehabilitation. |
PC Magazine
May 3, 2006
Sebastian Rupley |
Head Conk Scientists have developed the Infrascanner. It's a handheld device from InfraScan designed to detect instantly whether hematoma (bleeding in the brain) is present. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Nurse Practitioner
March 2009
Patricia Weyland |
Warfarin Therapy Management :Tap in to New Ways to Slow the Clot Patients on warfarin require close monitoring in order to decrease their risk of clotting, while also decreasing their risk of bleeding. |
Nursing
March 2012
Susan Simmons |
Recognizing and preventing Acute stroke in women In women, stroke is the third leading cause of death, after heart disease and cancer, and the major cause of disability. |
Nursing Management
June 2010
Alison Trembly |
Stroke care in the 21st century Stroke care has changed dramatically in the last decade. This story emphasizes several key points about stroke in the 21st century. |
American Family Physician
December 15, 2003 |
How to Prevent a Stroke What is a stroke?... What increases my risk of having a stroke?... What can I do to lower my risk of having a stroke?... Can medicine help lower my risk of stroke?... etc. |
Nutrition Action Healthletter
September 2001 |
Brain Attack: What you need to know about stroke... |
